Combined use of medicinal plants and conventional medicines: risks and bioethical dilemmas in patients with chronic diseases

Authors

DOI:

https://doi.org/10.29057/mbr.v8i15.17163

Keywords:

Bioethic, herbal medicine, hypertension, Diabetes mellitus, herb-drug interactions

Abstract

Bioethics is an essential component of modern healthcare, particularly in the management of chronic diseases such as arterial hypertension and type 2 diabetes mellitus. In Mexico, these conditions show high prevalence and frequently coexist with traditional practices such as the use of medicinal plants. The combined use of herbal medicine and conventional drugs may generate clinical risks and relevant bioethical dilemmas, especially when professional supervision is lacking. This article analyzes, from a bioethical perspective, the main risks associated with this practice and the principles of autonomy, beneficence, non-maleficence, and justice involved, highlighting the role of healthcare professionals in providing safe and culturally sensitive guidance.

Downloads

Download data is not yet available.

References

Beauchamp TL, Childress JF. Principles of biomedical ethics. 8th ed. New York: Oxford University Press; 2019.

World Health Organization. Hypertension [Internet]. Geneva: WHO; 2023 [citado 2024 Nov 15]. Disponible en: https://www.who.int/news-room/fact-sheets/detail/hypertension

World Health Organization. Diabetes [Internet]. Geneva: WHO; 2023 [citado 2024 Nov 15]. Disponible en: https://www.who.int/news-room/fact-sheets/detail/diabetes

Instituto Nacional de Salud Pública (INSP). Encuesta Nacional de Salud y Nutrición (ENSANUT) 2023 [Internet]. Cuernavaca: INSP; 2023 [citado 2024 Nov 15]. Disponible en: https://ensanut.insp.mx

Barquera S, Hernández-Barrera L, Trejo-Valdivia B, Shamah-Levy T, Campos-Nonato I. Prevalence of diabetes and hypertension in Mexico: ENSANUT 2023 results. Salud Publica Mex. 2023;65(6):745–58. doi:10.21149/14701.

World Health Organization. WHO global report on traditional and complementary medicine 2019 [Internet]. Geneva: WHO; 2019 [citado 2024 Nov 15]. Disponible en: https://www.who.int/publications/i/item/978924151536

Comisión Nacional para el Conocimiento y Uso de la Biodiversidad (CONABIO). Plantas medicinales [Internet]. México: CONABIO; 2020 [citado 2024 Nov 15]. Disponible en: https://www.biodiversidad.gob.mx/diversidad/medicinal/plantas

Instituto Nacional de los Pueblos Indígenas (INPI). Plantas medicinales utilizadas por los pueblos indígenas de México [Internet]. México: INPI; 2022 [citado 2024 Nov 15]. Disponible en: https://www.gob.mx/inpi

Ellis LR, Zulfiqar S, Holmes M, Marshall L, Dye L, Boesch C. Hibiscus sabdariffa and cardiometabolic markers: systematic review and meta-analysis. Nutr Rev. 2022;80(6):1723-37. doi:10.1093/nutrit/nuab104

Giraldo-Silva L, Ferreira B, Rosa E, Dias ACP. Opuntia ficus-indica: phytochemistry and pharmacological activities: a systematic review. Plants (Basel). 2023;12(3):543. doi:10.3390/plants12030543

Sleiman C, Daou R-M, Al Hazzouri A, Hamdan Z, Ghadieh HE, Harbieh B, Romani M. Garlic and hypertension: efficacy, mechanism of action, and clinical implications. Nutrients. 2024;16(17):2895. doi:10.3390/nu16172895

Babos MB, Heinan M, Redmond L, Moiz F, Souza-Peres JV, Samuels V, et al. Herb-drug interactions: worlds intersect with the patient at the center. Medicines (Basel). 2021;8(8):44. doi:10.3390/medicines8080044

Nyulászi KI, Simon-Szabó Z, Pál S, Fodor M-A, Dénes L, Cseh MJ, et al. Cardiovascular effects of herbal products and their interaction with antihypertensive drugs: comprehensive review. Int J Mol Sci. 2024;25(12):6388. doi:10.3390/ijms25126388

Sujithra M, Puthiyedath R, Pillai ZS. Drug–herb interactions: a challenge and clinical concern in primary healthcare. Front Med (Lausanne). 2025;12:1657005. Doi:10.3389/fmed.2025.1657005.

Harnett JE, Desselle SP, Fernandes MB, et al. Defining and supporting a professional role for pharmacists associated with traditional and complementary medicines: a cross-country survey of pharmacists. Front Pharmacol. 2023;14:1215475. doi:10.3389/fphar.2023.1215475

Pan American Health Organization (PAHO). Inequidades en salud y grupos vulnerables en las Américas [Internet]. Washington (DC): PAHO; 2022 [citado 2024 Nov 15]. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC12634587/World Health Organization. Draft global traditional medicine strategy (2025–2034) / background & policy guidance [Internet]. Geneva: WHO; 2024 [citado 2024 Nov 15]. Disponible en: https://apps.who.int/gb/ebwha/pdf_files/EB156/B156_16-en.pdf

Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS). NOM-248-SSA1-2011 Buenas prácticas de fabricación para establecimientos dedicados a la fabricación de remedios herbolarios [Internet]. México: DOF/COFEPRIS; 2011 [citado 2024 Nov 15]. Disponible en: https://www.dof.gob.mx/nota_detalle.php?codigo=5178331&fecha=22/03/2012

COFEPRIS. NOM-072-SSA1-2012 Etiquetado de medicamentos y de remedios herbolarios [Internet]. México: DOF/COFEPRIS; 2012 [citado 2024 Nov 15]. Disponible en: https://www.dof.gob.mx/nota_detalle.php?codigo=5281592&fecha=21/11/2012

Gómez-Morales GB, et al. Prevalence of obesity, diabetes and hypertension in immigrant populations in northeastern Mexico. Front Public Health. 2024;11:1220753. doi:10.3389/fpubh.2023.1220753

Gómez-Morales GB, Rosas-Torres BS, Hernández-Jiménez WJ, Mattenberger-Cantú E, Vargas-Villarreal J, Almanza-Reyes H, et al. Prevalence of obesity, diabetes and hypertension in immigrant populations in northeastern Mexico. Front Public Health. 2023;11:1220753. Doi:10.3389/fpubh.2023.1220753

Downloads

Published

2026-07-05

How to Cite

Perez Maranto, M. B., Islas Avila, O., Solano Pérez, C., & Reynoso Vázquez, J. (2026). Combined use of medicinal plants and conventional medicines: risks and bioethical dilemmas in patients with chronic diseases. Mexican Bioethics Review ICSA, 8(15), 19–22. https://doi.org/10.29057/mbr.v8i15.17163